← back to search

Eun Hee Kim

CHA University · KR
Area of research
Molecular Biology · Health, Toxicology and Mutagenesis
Research interest
Research interests include Cell death mechanisms and regulation, Mercury impact and mitigation studies, Acute Myeloid Leukemia Research, and Melanoma and MAPK Pathways.
h-index
55
citations
11,254
works
297
NIH funding
primary concept
Medicine
email

Recent publications

SUN2 downregulation promotes breast cancer cell proliferation via NFATC4 upregulation
Biochemical and Biophysical Research Communications 2026cited by 0position: contributordoi
Dual role of p21 in regulating apoptosis and mitotic integrity in response to doxorubicin in colon cancer cells.
2025cited by 5position: contributordoi
Targeting RBM39 with Tasisulam enhances TRAIL-induced apoptosis through DR5 upregulation and Bcl-2 downregulation in renal cell carcinoma
Biochemical Pharmacology 2025cited by 4position: contributordoi
Akt enhances the vulnerability of cancer cells to VCP/p97 inhibition-mediated paraptosis.
2024cited by 16position: contributordoi
Synthetic Lethal and Convergent Biological Effects of Cancer-Associated Spliceosomal Gene Mutations
Cancer Cell 2018cited by 213position: middledoi
Genomic analysis of hairy cell leukemia identifies novel recurrent genetic alterations
Blood 2017cited by 114position: middledoi
SRSF2 Mutations Contribute to Myelodysplasia by Mutant-Specific Effects on Exon Recognition
Cancer Cell 2015cited by 564position: firstdoi
Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling
Molecular Cell 2015cited by 157position: middledoi
Hematopoietic Stem Cell Origin of <i>BRAF</i> V600E Mutations in Hairy Cell Leukemia
Science Translational Medicine 2014cited by 126position: middledoi
Efficacy of Intermittent Combined RAF and MEK Inhibition in a Patient with Concurrent BRAF- and NRAS-Mutant Malignancies
Cancer Discovery 2014cited by 82position: middledoi
Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo
The Journal of Experimental Medicine 2013cited by 321position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 4 papers (2024–2026)Omar Abdel‐Wahab · Presbyterian Hospital4 papers (2014–2017)Young Rock Chung · New York University3 papers (2014–2017)Michael F. Berger · Memorial Sloan Kettering Cancer Center3 papers (2014–2017)Kyeong Sook Choi · Ajou University2 papers (2024–2025)Martin S. Tallman · Midwestern University2 papers (2014–2017)Stephen S. Chung · Southwestern Medical Center2 papers (2014–2017)Neal Rosen · Memorial Sloan Kettering Cancer Center2 papers (2014–2014)Jae H. Park · Memorial Sloan Kettering Cancer Center2 papers (2014–2017)Raajit K. Rampal · Icahn School of Medicine at Mount Sinai2 papers (2014–2014)Lu Wang · University of Rochester Medical Center1 papers (2017–2017)Yue Li · University of Leeds1 papers (2015–2015) · 1 papers (2015–2015)Min Kyung Kim · The Ohio State University1 papers (2015–2015)David B. Solit · New York Oncology Hematology1 papers (2014–2014)Minal Patel · Barts Health NHS Trust1 papers (2014–2014)In Young Kim · Ajou University1 papers (2024–2024)Gyesoon Yoon · Ajou University1 papers (2024–2024)Eun Kyung Choi · 1 papers (2024–2024)Chae-Ok Yun · Hanyang University1 papers (2024–2024)